Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes

NCT06964620 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Impaired Glucose Tolerance

Interventions

DRUG: Sanggua tablets
DRUG: Placebo

Sponsor

Tongji Hospital